Effects of hyperacute blood pressure and heart rate on stroke outcomes after intravenous tissue plasminogen activator

被引:27
|
作者
Tomii, Yasuhiro [1 ]
Toyoda, Kazunori [1 ]
Nakashima, Takahiro [1 ]
Nezu, Tomohisa [1 ]
Koga, Masatoshi [2 ]
Yokota, Chiaki [1 ]
Nagatsuka, Kazuyuki [3 ]
Minematsu, Kazuo [1 ]
机构
[1] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka 5658565, Japan
[2] Natl Cerebral & Cardiovasc Ctr, Div Stroke Care Unit, Suita, Osaka 5658565, Japan
[3] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Suita, Osaka 5658565, Japan
基金
日本学术振兴会;
关键词
blood pressure; heart rate; hypertension; outcome; stroke; thrombolysis; tissue plasminogen activator; ACUTE ISCHEMIC-STROKE; SAFE IMPLEMENTATION; PROGNOSTIC-SIGNIFICANCE; DIFFERENT SUBTYPES; CLINICAL-TRIAL; THROMBOLYSIS; ALTEPLASE; ASSOCIATION; VARIABILITY; PREDICTORS;
D O I
10.1097/HJH.0b013e32834a764e
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background and purpose The present study clarifies associations between stroke outcomes after intravenous tissue plasminogen activator (tPA) and blood pressure (BP) as well as heart rate (HR) profiles. Methods We assessed 125 patients with stroke who received tPA within 3 h of onset. We obtained baseline, mean, maximum, minimum, and coefficient of variation values for BP and HR during the initial 24 h. The primary outcome was independence at 3 months corresponding to a modified Rankin Scale score of 2 or less. The secondary outcomes were early neurological improvement at 24 h and intracerebral hemorrhage (ICH) within 36 h. Results Among the patients, 64 (51%) achieved independence, 66 (53%) early improvement, and 26 (21%) developed ICH. The 24-h time courses of SBP (P = 0.033), pulse pressure (PP, P = 0.007), and HR (P < 0.001) were lower among patients who reached independence than among those who did not. After multivariate adjustment, 24-h mean levels of SBP (odds ratio 0.69, 95% confidence interval 0.48-0.97, per 10-mmHg increase), PP (0.63, 0.41-0.94), and HR (0.59, 0.42-0.80, per 10-bpm increase) were inversely associated with independence, as were their maximum and minimum values. In particular, mean SBP values were inversely associated with independence at 8-16 and 16-24 h (0.73, 0.54-0.97 and 0.66, 0.47-0.91, respectively), but not at 0-8 h (0.79, 0.57-1.07). Baseline and maximum SBP were inversely associated with early improvement. Maximum and coefficient of variation of SBP were associated with ICH. Conclusion Lower SBP, PP, and HR values during the initial 24 h after tPA, especially at 8 h thereafter, were associated with independence at 3 months. J Hypertens 29:1980-1987 (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:1980 / 1987
页数:8
相关论文
共 50 条
  • [31] Intravenous tissue plasminogen activator, ischemic stroke, and the risk of Kounis Syndrome
    Kounis, Nicholas G.
    Kouni, Sophia N.
    Kounis, George N.
    Kounis, Sophia A.
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2011, 14 (03) : 223 - U86
  • [32] Intravenous tissue plasminogen activator for acute stroke in California: Recipients and resources
    Birbeck, GL
    Cui, XP
    Zingmond, DS
    Vickrey, BG
    CEREBROVASCULAR DISEASES, 2004, 17 (04) : 341 - 343
  • [33] Acute ischemic stroke: improving access to intravenous tissue plasminogen activator
    Turner, Ashby C.
    Schwamm, Lee H.
    Etherton, Mark R.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (05) : 277 - 287
  • [34] Safety and efficacy of intravenous tissue plasminogen activator in acute ischemic stroke
    Rajapa, S.
    Sivakumar, S.
    Arjundas, D.
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 133 - 133
  • [35] Medicolegal Considerations with Intravenous Tissue Plasminogen Activator in Stroke: A Systematic Review
    Bhatt, Archit
    Chaudhari, Dhara
    Kassab, Mounzer
    Ackerman, Glen
    Hussain, Syed
    Majid, Arshad
    Safdar, Adnan
    NEUROLOGY, 2011, 76 (09) : A631 - A631
  • [36] Update on Intravenous Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke
    Fugate, Jennifer E.
    Rabinstein, Alejandro A.
    MAYO CLINIC PROCEEDINGS, 2014, 89 (07) : 960 - 972
  • [37] Intravenous recombinant tissue plasminogen activator in a pregnant woman with cardioembolic stroke
    Wiese, Kathleen M.
    Talkad, Arun
    Mathews, Maureen
    Wang, David
    STROKE, 2006, 37 (08) : 2168 - 2169
  • [38] The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke
    Kahn, JH
    Viereck, J
    Kase, C
    Jeerakathil, T
    Romero, R
    Mehta, SD
    Kociol, R
    Babikian, V
    JOURNAL OF EMERGENCY MEDICINE, 2005, 29 (03): : 273 - 277
  • [39] Adding to the effectiveness of intravenous tissue plasminogen activator for treating acute stroke
    Grotta, JC
    CIRCULATION, 2003, 107 (22) : 2769 - 2770
  • [40] Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator
    Alexandrov, AV
    Grotta, JC
    NEUROLOGY, 2002, 59 (06) : 862 - 867